PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- PA-23-230
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.084 Prevention of Disease, Disability, and Death by Infectious Diseases
- 93.173 Research Related to Deafness and Communication Disorders
- 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- 93.855 Allergy and Infectious Diseases Research
- 93.859 Biomedical Research and Research Training
- 93.866 Aging Research
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Small Businesses
- Full announcement
Opportunity details come from Grants.gov. Updated .
Synopsis
This Notice of Funding Opportunity (NOFO), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA. This Parent Funding Opportunity Announcement does not accept clinical trials.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity